Nelida I. Noguera

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Editorial: Evaluating differentiation therapy and biomarkers in myeloid malignancies.

Editorial: Evaluating differentiation therapy and biomarkers in myeloid malignancies.

Journal: Frontiers in oncology

Published: April 28, 2026

New horizons for hope of cure in acute myeloid leukemia through immunotherapy: a narrative review.

New horizons for hope of cure in acute myeloid leukemia through immunotherapy: a narrative review.

Journal: Expert review of anticancer therapy

Published: January 08, 2026

Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia.

Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia.

Journal: Expert opinion on pharmacotherapy

Published: October 27, 2025

Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications.

Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications.

Journal: Journal of personalized medicine

Published: June 26, 2025

Correction: Niscola et al. Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies. Curr. Oncol. 2024, 31, 6632-6658.

Correction: Niscola et al. Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies. Curr. Oncol. 2024, 31, 6632-6658.

Journal: Current oncology (Toronto, Ont.)

Published: May 27, 2025

Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2-Related Factor 2 Function in Leukemia and Other Cancers.

Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2-Related Factor 2 Function in Leukemia and Other Cancers.

Journal: Cells

Published: April 14, 2025

PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.

PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.

Journal: Leukemia

Published: March 21, 2025

PKP1 promotes lung cancer by modulating energy metabolism through stabilization of PFKP.

PKP1 promotes lung cancer by modulating energy metabolism through stabilization of PFKP.

Journal: Biomarker research

Published: March 07, 2025

Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies.

Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies.

Journal: Current oncology (Toronto, Ont.)

Published: September 13, 2024

Characterization of a novel IDH2-R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation.

Characterization of a novel IDH2-R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation.

Journal: British journal of haematology

Published: September 19, 2023

YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells.

YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells.

Journal: Cancers

Published: June 19, 2023

Effects of Triheptanoin on Mitochondrial Respiration and Glycolysis in Cultured Fibroblasts from Neutral Lipid Storage Disease Type M (NLSD-M) Patients.

Effects of Triheptanoin on Mitochondrial Respiration and Glycolysis in Cultured Fibroblasts from Neutral Lipid Storage Disease Type M (NLSD-M) Patients.

Journal: Biomolecules

Published: January 29, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026